RxDoctor Payments Data

Allie Thomas-Fannin, MD

Psychiatry · Vincennes, INNPI 1942566708

Payments from drug & device makers

$2,586in general payments, 2019–2025

Across 186 payments — averaging $13.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$536
  • Sunovion Pharmaceuticals Inc.$465
  • Otsuka America Pharmaceutical, Inc.$278
  • Alkermes, Inc.$261
  • Indivior Inc.$159
  • AbbVie$149
  • plus $738 from 12 others

What the payments were for

  • Food & beverage$2,585100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,586 in reported general payments places this provider in the 75th percentile of 514 psychiatry providers in Indiana.

See all psychiatry providers in Indiana

Medicare billing

Part B allowed, 2024
$14,318
Medicare patients
78
Services billed
175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl36$55,684
Invega SustennaPaliperidone Palmitate20$49,545
RexultiBrexpiprazole29$43,014
Naltrexone Hcl28$3,240
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine44$1,977
Clozapine39$1,919
Aripiprazole16$1,679
Desipramine Hcl13$1,611
Trazodone Hcl80$1,416
Bupropion XlBupropion Hcl69$1,236
Buspirone Hcl73$1,104
Quetiapine Fumarate80$1,097
Quetiapine Fumarate ErQuetiapine Fumarate26$1,077
Prazosin Hcl58$990
Olanzapine55$955

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$149$55,68436 claims
Johnson & JohnsonInvega Sustenna$536$49,54520 claims
Otsuka America Pharmaceutical, Inc.Rexulti$278$43,01429 claims
Lilly USA, LLCOlanzapine$15$95555 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 514 psychiatry providers in Indiana.

Other psychiatry in Vincennes

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →